Related Experiment Video
Updated: Oct 1, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
6-Methoxyflavone induces S-phase arrest through the CCNA2/CDK2/p21CIP1 signaling pathway in HeLa cells
Chaihong Zhang1,2, Yuchong Quan3, Lijuan Yang1,2
1The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
Abstract:
This study aimed to elucidate the specific anticancer mechanism of 6-methoxyflavone in HeLa cells. A total of 178 putative targets of 6-methoxyflavone were obtained from the PharmMapper database. Microarray analyses, transcriptome sequencing analyses, functional enrichment analyses, and gene set enrichment analyses were performed to preliminarily explore the roles and mechanisms of the 178 targets in cervical cancer. Cell counting kit-8, cell cycle assays, polymerase chain reactions, and western blotting were used to clarify the mechanism of action of 6-methoxyflavone. Molecular docking and noncovalent interaction analyses were performed to further confirm the mechanism of action in three-dimensional structures. Functional enrichment analyses and gene set enrichment analyses indicated that high mRNA expression of cyclin A2 (CCNA2) and cyclin-dependent kinase 2 (CDK2) stimulated cell cycle progression in cervical cancer. Cell proliferation and cycle assays, transcriptome sequencing, polymerase chain reactions, and western blotting revealed that 6-methoxyflavone inhibited HeLa cell proliferation and induced S-phase arrest via the CCNA2/CDK2/ cyclin-dependent kinase inhibitor 1A (p21CIP1) pathway. Molecular docking and noncovalent interaction analyses showed that 6-methoxyflavone had the strongest affinity toward, inhibitory effect on, and noncovalent interactions with CDK2, and that the combination of CDK2 and CCNA2 enhanced these effects. An analysis of clinical characteristics showed that 6-methoxyflavone might be related to six clinicopathological parameters of cervical cancer patients. 6-Methoxyflavone induces S-phase arrest in HeLa cells via the CCNA2/CDK2/p21CIP1 pathway.
Insights
6-Methoxyflavone inhibits cervical cancer cell proliferation by inducing S-phase arrest. This anticancer effect is mediated through the cyclin A2/cyclin-dependent kinase 2/p21CIP1 pathway, impacting cell cycle progression.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cervical cancer remains a significant global health concern, necessitating novel therapeutic strategies.
- Understanding the molecular mechanisms underlying cancer progression is crucial for developing targeted treatments.
- Flavonoids, like 6-methoxyflavone, are being investigated for their potential anticancer properties.
Purpose of the Study:
- To elucidate the specific anticancer mechanism of 6-methoxyflavone in HeLa cervical cancer cells.
- To identify the molecular targets and pathways affected by 6-methoxyflavone.
- To investigate the interaction of 6-methoxyflavone with key cell cycle regulatory proteins.
Main Methods:
- Utilized PharmMapper database for target identification, followed by microarray and transcriptome sequencing.
- Performed functional and gene set enrichment analyses to explore target roles in cervical cancer.
- Employed cell proliferation assays, cell cycle analysis, PCR, and Western blotting to confirm mechanisms.
- Conducted molecular docking and noncovalent interaction analyses for structural validation.
Main Results:
- Identified 178 putative targets for 6-methoxyflavone, with high mRNA expression of cyclin A2 (CCNA2) and cyclin-dependent kinase 2 (CDK2) linked to cervical cancer cell cycle progression.
- 6-Methoxyflavone significantly inhibited HeLa cell proliferation and induced S-phase arrest.
- The mechanism involves the CCNA2/CDK2/cyclin-dependent kinase inhibitor 1A (p21CIP1) pathway.
- Molecular docking revealed strong affinity and inhibitory effects of 6-methoxyflavone on CDK2, enhanced by CCNA2 interaction.
Conclusions:
- 6-Methoxyflavone exhibits anticancer activity in HeLa cells by inducing S-phase arrest.
- The primary mechanism involves the modulation of the CCNA2/CDK2/p21CIP1 pathway, crucial for cell cycle regulation.
- 6-Methoxyflavone demonstrates potential as a therapeutic agent for cervical cancer, warranting further investigation into its clinical relevance.
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
DNA Damage Can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

